GPBAR1 and Hepatic steatosis: Genetic ablation of TGR5 has been shown to make mice more susceptible to impaired glucose tolerance, hepatic insulin resistance, hepatic steatosis and fibrosis, as well as altered bile acid metabolism [9,25,26].